Screening trends in ''at-risk'' families for prostate cancer

By Cormier L.   Azzouzi R.   Gundesli M.   Valeri A.   Fournier G.   Cussenot O.   Mangin P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 5-5

Elsevier

Access to resources Recommend Favorite

CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden

By Wagenius M.   Borg Å.   Johansson L.   Giwercman A.   Bratt O.  

Scandinavian Journal of Urology and Nephrology, Vol. 40, Iss. 1, 2006-01 ,pp. : 23-25

Informa Healthcare

Access to resources Recommend Favorite

Novel region of interest in chromosome 11 and other putative regions identified in a genome-wide scan in finnish hereditary prostate cancer families

By Matikainen M.   Schleutker J.   Gillanders E.   Baffoe-Bonnie A.   Jones M.P.   Kainu T.   Markey C.   Koivisto P.   Tammela T.   Bailey-Wilson J.   Trent J.   Kallioniemi O.-P.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 8-8

Elsevier

Access to resources Recommend Favorite

Impact of prostate cancer screening on health-related quality of life in at-risk families

By Cormier L.   Guillemin F.   Valeri A.   Fournier G.   Cussenot O.   Mangin P.   Litwin M.S.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 901-906

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite